BIIB vs VRT · P/E 21, rev $9.89B vs P/E 80, rev $10.23B
Biogen Inc (BIIB) versus Vertiv Holdings Co (VRT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Vertiv Holdings Co (VRT) is a electrical equipment & parts company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported VRT revenue for 2025-12-31 was $10.23B. Net income was $1.33B. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. VRT currently screens at market cap $121.99B and trailing P/E 79.8.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. VRT currently screens at market cap $121.99B and trailing P/E 79.8.
Not investment advice. Open the BIIB and VRT stock pages for the full models.
Not investment advice.